mk-1167
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 18, 2023 (NCT06625840)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07266818 | Phase 1 | Dec 17, 2025 | Merck |
| NCT06721156 | Phase 2 | Dec 31, 2024 | Merck |
| NCT06285240 | Phase 1 | Mar 28, 2024 | Merck |
| NCT06703463 | Phase 1 | Oct 17, 2023 | Merck |
| NCT06625840 | Phase 1 | Sep 18, 2023 | Merck |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 5 | 5 | 2 | 2023 |
1 organizations
Page 1 / 1